MEDIZONE CANADA LTD
DEFA14C, 1996-06-13
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: WESTMARK GROUP HOLDINGS INC, S-8, 1996-06-13
Next: PHONETEL TECHNOLOGIES INC, 8-K/A, 1996-06-13







                                  June 10, 1996










By EDGAR
- --------

United States Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

         Re:  Medizone Canada Limited
              CIK:  0000821172       

Dear Sir or Madam:

          Transmitted with this letter is Medizone Canada Limited's  Information
Statement for its 1996 annual meeting, to be held on July 10, 1996.

                                 Very truly yours,




                                 Andrew E. Goldstein


Enclosures


AEG/an


<PAGE>
                             MEDIZONE CANADA LIMITED
                              123 East 54th Street
                                    Suite 7B
                            New York, New York 10022



DEAR FELLOW STOCKHOLDER:


          On behalf of the Board of Directors,  I cordially invite you to attend
the Annual Meeting of Stockholders of Medizone Canada Limited (the "Company") to
be held on Wednesday,  July 10, 1996,  at 12:00  o'clock noon (Eastern  Daylight
Savings  Time) at The  Loews  New York  Hotel,  Lexington  Avenue  and East 51st
Street,  New York,  New York 10022.  This year, you are being asked to elect the
Company's directors and ratify the appointment of independent auditors.

          For the reasons set forth in the accompanying  information  statement,
your  Board  of  Directors   unanimously   recommends  that  you  vote  for  (i)
Management's nominees for directors and (ii) the ratification of the appointment
of Andersen Andersen & Strong, L.C. as the Company's independent auditors.

                                         Very truly yours,



                                         Joseph S. Latino, Ph.D.
                                         Director, President and
                                         Chief Executive Officer

Dated: June 10, 1996


You are welcome to attend the Annual  Meeting and vote your shares.  The Company
is not asking you for a proxy and you are requested not to send a proxy.
<PAGE>
                             MEDIZONE CANADA LIMITED
                              123 East 54th Street
                                    Suite 7B
                            New York, New York 10022

                              --------------------

                    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
                            TO BE HELD JULY 10, 1996


          NOTICE IS HEREBY  GIVEN that the Annual  Meeting  of  Stockholders  of
Medizone  Canada  Limited (the  "Company")  will be held on Wednesday,  July 10,
1996,  at 12:00 o'clock noon  (Eastern  Daylight  Savings Time) at The Loews New
York Hotel, Lexington Avenue and East 51st Street, New York, New York 10022, for
the purpose of considering and voting upon the following proposals:

          1.   To elect three  directors  to serve as the Board of  Directors of
               the Company until the next Annual Meeting of Stockholders;

          2.   To ratify the appointment of Andersen Andersen & Strong,  L.C. as
               the Company's  independent  auditors for the calendar year ending
               December 31, 1996; and

          3.   Such other business as may properly come before the meeting.

          The close of  business on May 28,  1996,  has been fixed as the record
date for determining the  stockholders  entitled to notice of and to vote at the
meeting and any  adjournment  thereof,  and only  stockholders of record on such
date shall be entitled to notice of and to vote at the meeting.

          THE COMPANY IS NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO
SEND A PROXY.

                                        By Order of the Board of Directors



                                        Joseph S. Latino, Ph.D.
                                        Director, President and
                                        Chief Executive Officer

Dated: June 10, 1996

<PAGE>

                              INFORMATION STATEMENT

                             MEDIZONE CANADA LIMITED
                              123 East 54th Street
                                    Suite 7B
                            New York, New York 10022

                         ANNUAL MEETING OF STOCKHOLDERS


          This information  statement is furnished to stockholders in connection
with the  Annual  Meeting  of  Stockholders  of  Medizone  Canada  Limited  (the
"Company")  to be held on  Wednesday,  July  10,  1996,  at 12:00  o'clock  noon
(Eastern  Daylight  Savings Time) at The Loews New York Hotel,  Lexington Avenue
and East 51st Street, New York, New York 10022, and at any adjournment thereof.

Voting

          At the close of business  on May 28,  1996,  36,493,333  shares of the
Company's common stock,  $.001 par value ("Common Stock"),  were outstanding and
eligible for voting at the meeting.  Each  stockholder  of record is entitled to
one vote for each share held on all  matters to come  before the  meeting.  Only
stockholders  of record at the close of business on April 25, 1996, are entitled
to notice of and to vote at the meeting.

          Other  than with  respect  to the  election  of  Directors,  all other
matters that are scheduled to come before the Annual Meeting require an approval
of the majority of the shares of stock present and entitled to vote thereon.

Security Ownership of Certain Beneficial Owners

          The following table set forth certain  information as of May 28, 1996,
pertaining to the beneficial  ownership of Common Stock, by (i) persons known to
the  Company  to own 5% or more  of the  outstanding  Common  Stock,  (ii)  each
director and nominee for director of the Company,  (iii) each executive  officer
named in the Summary  Compensation  Table below and (iv) directors and executive
officers of the Company as a group.  This information has been obtained from the
Company's records,  or from information  furnished directly by the individual or
entity to the Company.

<PAGE>


                                Number of Shares           Percentage of
Name and Address                Beneficially Owned         Total Outstanding
- ----------------                ------------------         -----------------

Medizone International, Inc.         24,304,560                  66.6%
123 East 54th Street
Suite 7B
New York, NY 10022

Joseph S. Latino, Ph.D                  -0-                      -0-
690 East 19th Street
Brooklyn, NY 11230

George Handel                           -0-                      -0-
1408 Melrose Avenue
Melrose Park, PA 19126

John D. Pealer                          285,100                   *
355 N. 21st Street
Camp Hill, PA 17011

Arthur P. Bergeron                      -0-                      -0-
40 Grove Street
Wellesly, MA 02181

All present directors                   585,100                1.46%
and executive officers
as a group (4 persons)

- ----------------------------------
                                               
* Indicates less than 1%



<PAGE>

                              ELECTION OF DIRECTORS

          Pursuant to the Company's By-Laws, a Board of Directors, consisting of
three  members,  is to be elected at the Annual  Meeting.  The  nominees  to the
Company's  Board of Directors are the present,  director of the Company and have
served, variously, since November 1992 and September 1993.

     The Board of Directors has nominated and management recommends the election
of the persons listed below as directors.  To be elected, a nominee must receive
the affirmative  vote of a plurality of the votes cast by the shares present and
entitled to vote,  in person or by proxy,  at the Annual  Meeting.  Accordingly,
abstentions or broker  non-votes as to the election of directors will not effect
the election of the candidates receiving the plurality of the votes.

                                                            Has Served as
Name                Age    Previous Occupation              Director Since
- ----                ---    -------------------              --------------

Joseph S. Latino    38     President, Director and                1993
                           Chief Executive Officer
                           of the Company

John D. Pealer      76     President and Chief Executive          1992
                           Officer of Pealer's Inc.
                           a real estate development company

George Handel       68     President, Hantex Mills, a             1992
                           dry goods firm, and Vice
                           President, Handel & Co., a
                           wholesale dry goods firm

<PAGE>
Biographies of Nominees

     Joseph S.  Latino,  Ph.D.,  was  appointed  President  and Chief  Operating
Officer  of the  Company  in  November  1992  and was  elected  to the  Board of
Directors on September  21, 1993.  He was named Chief  Executive  Officer of the
Company in March 1995. He holds the same  position  with the  Company's  parent,
Medizone  International,  Inc.  ("MII").  His affiliation with the Company dates
from 1986,  when he was named MII's Director of Research.  Dr. Latino received a
Bachelor of Science degree in 1978 from Brooklyn  College of the City University
of New York in Biology and  Chemistry.  He received his Doctor of  Philosophy in
Biochemistry  in 1984  from  City  University  of New York.  Dr.  Latino  became
Director of Special  Hematology/Oncology  Laboratory  at The  Brooklyn  Hospital
Center,  Brooklyn,  New York in 1984,  where  he was  employed  until he went on
sabbatical  in December  1994. In 1994,  Dr. Latino was  designated as the Basic
Science Research Coordinator for The Brooklyn Hospital Center and is a member of
the Investigational/Institutional Review Board of that institution. In 1986, Dr.
Latino became an Assistant Professor of Medicine,  Division of Hematology at the
Health Science Center at Brooklyn,  State  University of New York, as well as Ad
Hoc  Research  Advisor for The  Brooklyn  Hospital  Center.  In 1987 he became a
Research Educator for The Hematology/Oncology Fellowship Program at the Brooklyn
Hospital Center. Dr. Latino currently devotes substantially his full time to the
operations of the Company and MII.

     George  Handel  became a director of the  Company in November  1992 and has
served as the  Company's  Secretary  since  November 24, 1993. He holds the same
positions with MII. Mr. Handel, who attended Temple University,  is President of
Hantex Mills, a dry goods firm established in 1975, and Vice-President of Handel
& Co., a wholesale dry goods firm established in 1923.

     John D. Pealer  became a director of the  Company in November  1992.  He is
also a director of MII. Mr.  Pealer has been the  president of Pealer's  Inc., a
family-owned  corporation  engaged in the  business of real  estate  development
since 1949.

Committees and Meetings of the Board of Directors

     The Board of Directors does not have an audit,  nominating or  compensation
committee.

     During 1994, there were no meetings of the Board of Directors.


                             EXECUTIVE COMPENSATION

     The executive officers of the Company serve without compensation. They hold
the same positions with MII and are compensated by that entity.


          RATIFICATION OF APPOINTMENT OF INDEPENDENT PUBLIC ACCOUNTANTS

     Andersen Andersen & Strong, L.C. have been the principal accountants of the
Company  during  1994  and  have  been  selected  as  the  Company's   principal
accountants for the current calendar year.  Representatives of Andersen Andersen
& Strong, L.C. are not expected to be present at the Annual Meeting.

     If,  prior to the next  annual  meeting  of  stockholders,  such firm shall
decline to act or otherwise  becomes  incapable of acting,  or if its engagement
shall  be  otherwise  discontinued  by the  Board  of  Directors,  the  Board of
Directors  will appoint other  independent  auditors whose  appointment  for any
period  subsequent  to the next annual  meeting  will be subject to  stockholder
approval at such meeting.


                       SUBMISSION OF STOCKHOLDER PROPOSALS

     Any  stockholder  desiring  to  submit a  proposal  for  action at the next
meeting of  stockholders  which the  stockholder  desires to be presented in the
Company's  Information Statement with respect to such meeting should submit such
proposal to the Company at its  principal  place of business no later than March
31, 1997.



<PAGE>

                                  OTHER MATTERS

     The Board of Directors  did not know,  within a reasonable  time before the
commencement of this solicitation,  of any other business to be presented at the
Annual  Meeting,  constituting a proper subject for action by the  stockholders,
other than as set forth in this Information Statement.

     A list of  stockholders of record of the Company as of May 28, 1996 will be
available for  inspection by  stockholders  prior to the Annual  Meeting  during
normal  business  hours at the offices of the  Company at 123 East 54th  Street,
Suite 7B, New York, New York 10022, and at the Annual Meeting.

     THE COMPANY'S  1995 FORM 10-K ANNUAL REPORT TO THE  SECURITIES AND EXCHANGE
COMMISSION,  EXCLUSIVE  OF  EXHIBITS,  WILL  BE  MAILED  WITHOUT  CHARGE  TO ANY
STOCKHOLDER  ENTITLED TO VOTE AT THE MEETING,  UPON WRITTEN REQUEST TO: MEDIZONE
INTERNATIONAL,  INC., 123 EAST 54TH STREET,  SUITE 7B, NEW YORK, NEW YORK 10022,
ATTENTION: SECRETARY.

                                   By Order of the Board of Directors
                                   Joseph S. Latino, Ph.D.
                                   Director

Dated:  June 10, 1996


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission